Alan Moore

1.4k total citations
28 papers, 1.0k citations indexed

About

Alan Moore is a scholar working on Pharmacology, Rheumatology and Surgery. According to data from OpenAlex, Alan Moore has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Rheumatology and 6 papers in Surgery. Recurrent topics in Alan Moore's work include Inflammatory mediators and NSAID effects (8 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Neuropeptides and Animal Physiology (5 papers). Alan Moore is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Neuropeptides and Animal Physiology (5 papers). Alan Moore collaborates with scholars based in Switzerland, United States and United Kingdom. Alan Moore's co-authors include H. Pöhlmann, Maria Luíza Giraldes de Manreza, Sérgio Antônio Antoniuk, Natalio Fejerman, Marilisa M. Guerreiro, Carlos A.M. Guerreiro, W. Christe, Bernhard J. Steinhoff, Martin J. Brodie and Silvia Kochen and has published in prestigious journals such as Circulation, Transplantation and Arthritis Research & Therapy.

In The Last Decade

Alan Moore

26 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Moore Switzerland 13 528 503 222 156 136 28 1.0k
M J Brodie United Kingdom 18 392 0.7× 488 1.0× 132 0.6× 89 0.6× 39 0.3× 34 974
Zhiming Wang China 15 294 0.6× 391 0.8× 108 0.5× 197 1.3× 23 0.2× 66 1.1k
Sydney Louis United States 15 385 0.7× 310 0.6× 136 0.6× 50 0.3× 57 0.4× 31 904
Osman Metin İpçioğlu Türkiye 18 55 0.1× 126 0.3× 69 0.3× 218 1.4× 111 0.8× 64 964
Lars L. Thomsen Denmark 21 529 1.0× 62 0.1× 51 0.2× 74 0.5× 32 0.2× 35 1.5k
Mine Kadıoğlu Türkiye 19 60 0.1× 133 0.3× 70 0.3× 143 0.9× 50 0.4× 49 905
Chun‐Hou Liao Taiwan 24 211 0.4× 80 0.2× 46 0.2× 339 2.2× 87 0.6× 120 1.7k
Vincent Shu United States 14 433 0.8× 378 0.8× 184 0.8× 95 0.6× 91 0.7× 22 955
Joseph Gimbel United States 19 54 0.1× 97 0.2× 102 0.5× 412 2.6× 519 3.8× 37 1.4k

Countries citing papers authored by Alan Moore

Since Specialization
Citations

This map shows the geographic impact of Alan Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Moore more than expected).

Fields of papers citing papers by Alan Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Moore. The network helps show where Alan Moore may publish in the future.

Co-authorship network of co-authors of Alan Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Moore. A scholar is included among the top collaborators of Alan Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Moore. Alan Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Richardson, Jonathan L., Alan Moore, Rebecca Bromley, et al.. (2023). Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project. Drug Safety. 46(5). 479–491. 12 indexed citations
3.
Poeta, Maurizio Del, Brian J. Ward, Benjamin Greenberg, et al.. (2022). Cryptococcal Meningitis Reported With Fingolimod Treatment. Neurology Neuroimmunology & Neuroinflammation. 9(3). 17 indexed citations
4.
Burkill, Sarah, Ayako Hiyoshi, Tomas Olsson, et al.. (2020). Comorbid disease burden among MS patients 1968–2012: A Swedish register–based cohort study. Multiple Sclerosis Journal. 27(2). 268–280. 9 indexed citations
5.
Geissbühler, Yvonne, et al.. (2020). An alternative to product-specific pregnancy registries? PRIM; PRegnancy outcomes Intensive Monitoring. Reproductive Toxicology. 94. 13–21. 5 indexed citations
6.
Capkun, Gorana, Frank Dahlke, Raquel Lahoz, et al.. (2015). Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Multiple Sclerosis and Related Disorders. 4(6). 546–554. 90 indexed citations
7.
8.
Mason, Howard, Gareth Evans, & Alan Moore. (2011). Urinary biomarkers and occupational musculoskeletal disorders in the lower limbs. Occupational Medicine. 61(5). 341–348. 5 indexed citations
9.
Schnitzer, Thomas J., B. Seriolo, Hartmut Schneider, et al.. (2011). A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis. Clinical Rheumatology. 30(11). 1433–1446. 11 indexed citations
10.
Dougados, Maxime, Alan Moore, Shaohua Yu, & Xavier Gitton. (2011). Patient flow diagram. Figshare. 2 indexed citations
11.
12.
13.
Tannenbaum, H, Francis Bérenbaum, Jean‐Yves Reginster, et al.. (2002). Lumiracoxib (Prexige) is effective in the treatment of osteoarthritis of the knee: a 13-week, placebo-controlled, active-comparator, double-blind study. Open Repository and Bibliography (University of Liège). 7 indexed citations
14.
Dinsmore, Jonathan, et al.. (2000). NO EVIDENCE FOR INFECTION OF HUMAN CELLS WITH PORCINE ENDOGENOUS RETROVIRUS (PERV) AFTER EXPOSURE TO PORCINE FETAL NEURONAL CELLS1. Transplantation. 70(9). 1382–1389. 91 indexed citations
15.
Pöhlmann, H., et al.. (1997). A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Research. 27(3). 195–204. 165 indexed citations
16.
Christe, W., Günter Krämer, H. Pöhlmann, et al.. (1997). A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Research. 26(3). 451–460. 170 indexed citations
17.
Guerreiro, Marilisa M., H. Pöhlmann, Maria Luíza Giraldes de Manreza, et al.. (1997). A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Research. 27(3). 205–213. 193 indexed citations
18.
Færestrand, Svein, et al.. (1994). Long‐Term Clinical Performance of a Central Venous Oxygen Saturation Sensor for Rate Adaptive Cardiac Pacing. Pacing and Clinical Electrophysiology. 17(8). 1355–1372. 18 indexed citations
19.
Seifert, George, et al.. (1991). In Vivo and In Vitro Studies of a Chronic Oxygen Saturation Sensor. Pacing and Clinical Electrophysiology. 14(10). 1514–1527. 11 indexed citations
20.
Connelly, Donald P., Larry C. Lasky, Richard M. Keller, & Alan Moore. (1980). Graphical Representation of Clinical Laboratory Data. PubMed Central. 3. 1841–1848. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M J Brodie Breakdown of academic impact, for papers by Zhiming Wang Breakdown of academic impact, for papers by Sydney Louis Breakdown of academic impact, for papers by Osman Metin İpçioğlu Breakdown of academic impact, for papers by Lars L. Thomsen Breakdown of academic impact, for papers by Mine Kadıoğlu Breakdown of academic impact, for papers by Chun‐Hou Liao Breakdown of academic impact, for papers by Vincent Shu Breakdown of academic impact, for papers by Joseph Gimbel
Rankless by CCL
2026